These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Nondermatophytic onychomycosis by Fusarium oxysporum in an immunocompetent host. Shah SR; Dalal BD; Modak MS J Mycol Med; 2016 Mar; 26(1):e18-21. PubMed ID: 26852190 [TBL] [Abstract][Full Text] [Related]
8. Onychomycosis caused by Fusarium solani in a woman with diabetes. Wu CY; Chen GS; Lan CC Clin Exp Dermatol; 2009 Dec; 34(8):e772-4. PubMed ID: 20055843 [TBL] [Abstract][Full Text] [Related]
10. Large-scale epidemiological study of the causal agents of onychomycosis: mycological findings from the Multicenter Onychomycosis Study of Terbinafine. Elewski BE Arch Dermatol; 1997 Oct; 133(10):1317-8. PubMed ID: 9382581 [No Abstract] [Full Text] [Related]
11. Green Nail Caused by Onychomycosis Coinfected With Pseudomonas aeruginosa. Monteagudo B; Figueroa O; Suárez-Magdalena O; Méndez-Lage S Actas Dermosifiliogr (Engl Ed); 2019 Nov; 110(9):783-785. PubMed ID: 31010574 [No Abstract] [Full Text] [Related]
12. Fatal hyalohyphomycosis following Fusarium onychomycosis in an immunocompromised patient. Arrese JE; Piérard-Franchimont C; Piérard GE Am J Dermatopathol; 1996 Apr; 18(2):196-8. PubMed ID: 8739996 [TBL] [Abstract][Full Text] [Related]
13. Onychomycosis insensitive to systemic terbinafine and azole treatments reveals non-dermatophyte moulds as infectious agents. Baudraz-Rosselet F; Ruffieux C; Lurati M; Bontems O; Monod M Dermatology; 2010; 220(2):164-8. PubMed ID: 20110639 [TBL] [Abstract][Full Text] [Related]
14. [Fungal nail diseases. What the pharmacist can do for his clients]. Seebacher C Med Monatsschr Pharm; 2001 Dec; 24(12):404-6. PubMed ID: 11793822 [No Abstract] [Full Text] [Related]
15. [Diagnosis of non dermatophyte onychomycosis ant its relevance for treatment]. Monod M; Lurati M; Baudraz-Rosselet F Rev Med Suisse; 2013 Apr; 9(380):730-3. PubMed ID: 23621043 [TBL] [Abstract][Full Text] [Related]
16. Malassezia furfur onychomycosis in an immunosuppressed liver transplant recipient. Ertam I; Aytimur D; Alper S Indian J Dermatol Venereol Leprol; 2007; 73(6):425-6. PubMed ID: 18032868 [No Abstract] [Full Text] [Related]
17. A case of fusariosis in an immunocompromised patient successfully treated with liposomal amphotericin B. Selleslag D Acta Biomed; 2006; 77 Suppl 2():32-5. PubMed ID: 16918066 [TBL] [Abstract][Full Text] [Related]
18. Onychomycosis caused by Fusarium sp in Sri Lanka: prevalence, clinical features and response to itraconazole pulse therapy in six cases. Ranawaka RR; de Silva N; Ragunathan RW J Dermatolog Treat; 2008; 19(5):308-12. PubMed ID: 19160539 [TBL] [Abstract][Full Text] [Related]
19. Antifungal susceptibility patterns of yeasts and filamentous fungi isolated from nail infection. Ataides FS; Chaul MH; El Essal FE; Costa CR; Souza LK; Fernandes OF; Silva MR J Eur Acad Dermatol Venereol; 2012 Dec; 26(12):1479-85. PubMed ID: 22049990 [TBL] [Abstract][Full Text] [Related]
20. Yellow nail syndrome and onychomycosis. Experience with itraconazole pulse therapy combined with vitamin E. Luyten C; André J; Walraevens C; De Doncker P Dermatology; 1996; 192(4):406-8. PubMed ID: 8864394 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]